Blood and marrow transplantation strategies have changed significantly over the past four decades; but recipients still experience excess mortality that translates into 8.7 years of life lost, according to researchers in UAB’s Institute for Cancer Outcomes and Survivorship.

Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.

New findings include a significant increase in risk of death among patients who had recently had chemotherapy.